Literature DB >> 8058147

Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts.

K Ricker1, M C Koch, F Lehmann-Horn, D Pongratz, M Otto, R Heine, R T Moxley.   

Abstract

We describe three families with a dominantly inherited disorder. Affected individuals have myotonia, proximal muscle weakness, and cataracts. There was no abnormal CTG repeat expansion of the myotonic dystrophy (DM) gene in DNA from blood and muscle. The structure of the three families permitted linkage analysis, and there is no linkage to the gene loci for DM or to the loci for the muscle chloride channel disorders or muscle sodium channel disorders. The collection of symptoms in these three families seems to represent a new disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058147     DOI: 10.1212/wnl.44.8.1448

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  49 in total

Review 1.  A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature.

Authors:  G Meola; V Sansone
Journal:  Ital J Neurol Sci       Date:  1996-10

2.  [Musculoskeletal pain as the most prominent feature in myotonic dystrophy type 2].

Authors:  A George; C Schneider-Gold; K Reiners; C Sommer
Journal:  Schmerz       Date:  2006-09       Impact factor: 1.107

Review 3.  Muscle channelopathies and critical points in functional and genetic studies.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 4.  Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.

Authors:  F Lehmann-Horn; K Jurkat-Rott; R Rüdel
Journal:  Acta Myol       Date:  2008-12

5.  Diagnostic odyssey of patients with myotonic dystrophy.

Authors:  James E Hilbert; Tetsuo Ashizawa; John W Day; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  J Neurol       Date:  2013-06-27       Impact factor: 4.849

6.  Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2.

Authors:  Federica Montagnese; Stefania Mondello; Stephan Wenninger; Wolfram Kress; Benedikt Schoser
Journal:  J Neurol       Date:  2017-10-30       Impact factor: 4.849

7.  Early onset posterior subscapular cataract in a series of myotonic dystrophy type 2 patients.

Authors:  C Papadopoulos; K Kekou; S Xirou; S Kitsiou-Tzeli; E Kararizou; G K Papadimas
Journal:  Eye (Lond)       Date:  2017-12-08       Impact factor: 3.775

8.  Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.

Authors:  Linda L Bachinski; Bjarne Udd; Giovanni Meola; Valeria Sansone; Guillaume Bassez; Bruno Eymard; Charles A Thornton; Richard T Moxley; Peter S Harper; Mark T Rogers; Karin Jurkat-Rott; Frank Lehmann-Horn; Thomas Wieser; Josep Gamez; Carmen Navarro; Armand Bottani; Andre Kohler; Mark D Shriver; Riitta Sallinen; Maija Wessman; Shanxiang Zhang; Fred A Wright; Ralf Krahe
Journal:  Am J Hum Genet       Date:  2003-09-10       Impact factor: 11.025

Review 9.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

10.  Direct molecular analysis of myotonic dystrophy in the German population: important considerations in genetic counselling.

Authors:  A Meiner; C Wolf; N Carey; A Okitsu; K Johnson; P Shelbourne; B Kunath; W Sauermann; H Thiele; P Kupferling
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.